HEC
Hudson Executive Capital Portfolio holdings
AUM
$135M
This Quarter Return
-7.2%
1 Year Return
+30.05%
3 Year Return
+142.48%
5 Year Return
+146.32%
10 Year Return
–
AUM
$199M
AUM Growth
+$199M
(-8.6%)
Cap. Flow
+$2.12M
Cap. Flow
% of AUM
1.07%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
2
Reduced
–
Closed
1
Top Buys
| 1 |
ACOR
Acorda Therapeutics, Inc.
ACOR
|
$2.85M |
| 2 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
$1.22M |
Top Sells
| 1 |
VIVO
Meridian Bioscience Inc
VIVO
|
$1.94M |
Sector Composition
| 1 | Healthcare | 73.58% |
| 2 | Financials | 26.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EGRX
1
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $57.9M | 29.13% |
971,000
+20,400
| +2% | +$1.22M |
|
|
CIT
2
DELISTED
CIT Group Inc.
CIT
| $52.5M | 26.42% |
1,070,857
| – | – |
|
3
AtriCure
ATRC
$1.84B
| $41.5M | 20.87% |
1,855,000
| – | – |
|
|
ACOR
4
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $21.1M | 10.63% |
893,500
+120,410
| +16% | +$2.85M |
|
|
CVRS
5
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
| $17.2M | 8.67% |
11,336,154
| – | – |
|
|
MGLN
6
DELISTED
Magellan Health Services, Inc.
MGLN
| $8.52M | 4.28% |
98,700
| – | – |
|
|
VIVO
7
DELISTED
Meridian Bioscience Inc
VIVO
| – | – |
-123,300
| Closed | -$1.94M |
|